$70.2 million of Net Revenue Q3 2024+34.6% Comparable Net Revenue GrowthBoth brands accelerating from Q2 2024+45.5% Obagi Medical and +23.5% Milk Makeup vs Q3 2023Adjusted EBITDA of $11.4 million, up +134.0% vs Q3 2023

LONDON, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ: WALD) (“Waldencast”), a global multi-brand beauty and wellness platform provided the details for its Third Quarter Fiscal 2024 conference call and webcast. As previously announced, the Company will issue its Third Quarter Fiscal 2024 results on November 20, 2024 after the close of the U.S. market.

NEW YORK, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Waldencast plc (NASDAQ: WALD) (“Waldencast” or the “Company”), a global multi-brand beauty and wellness platform, announced today that Hind Sebti, Kelly Brookie and Roberto Thompson have been appointed to its board of Directors (the “Board”), effective September 26, 2024. These executives bring extensive professional experience further enhancing the breadth of talent and expertise possessed by the Board. Ms. Brookie will replace Sarah Brown who has informed the Board of her intention to not renew her mandate ahead of the Company’s Annual General Meeting. The Company also announced that its Annual General Meeting is scheduled for October 28, 2024 during which the Company’s shareholders will be asked to vote on the renewal of Class I and Class II directors. Following this announcement, the Board will include 11 members, each of whom possesses significant expertise, particularly in the beauty, financial and consumer products sectors.

These New Products are the Latest Innovation to Obagi’s ELASTIDERM® Collection

$63.3 million of Net Revenue Q2 2024 +25.7% net revenue Comparable Growth: +30.9% Obagi Medical and +20.0% Milk Makeup vs Q2 2023 Adjusted EBITDA of $6.3 million, up +64.5% vs Q2 2023

NEW YORK, Aug. 21, 2024 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ: WALD) (“Waldencast”), a global multi-brand beauty and wellness platform, provided second quarter and first half fiscal 2024 earnings conference call and webcast information. As previously announced, the Company will report second quarter and first half fiscal 2024 earnings on August 27th, after the close of the U.S. stock market. The Company will conduct a conference call to discuss its earnings results on Wednesday, August 28, 2024 at 8:30am ET.

WHITE PLAINS, N.Y., Aug. 07, 2024 (GLOBE NEWSWIRE) -- Waldencast plc (NASDAQ: WALD) (“Waldencast” or the “Company”), a global multi-brand beauty and wellness platform, today announced that the Company will participate in the Canaccord Genuity 44th Annual Growth Conference being held at the InterContinental Boston Hotel in Boston, Massachusetts.

WHITE PLAINS, N.Y., June 27, 2024 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ: WALD) (“Waldencast”), a global multi-brand beauty and wellness platform, announced upcoming earnings release, conference call and webcast dates.

WHITE PLAINS, N.Y., May 30, 2024 (GLOBE NEWSWIRE) -- Waldencast plc (NASDAQ: WALD) (“Waldencast” or the “Company”), a global multi-brand beauty and wellness platform, today announced that the Company will participate in upcoming investor conferences.

$68.3 million of Net Revenue+21.0% Comparable Net Revenue: +20.6% Obagi Skincare and +21.5% Milk MakeupAdjusted EBITDA of $11.4 million, up +12.9% vs Q1 2023

NEW YORK, May 13, 2024 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ: WALD) (“Waldencast”), a global multi-brand beauty and wellness platform, announced that it will release its first quarter fiscal 2024 earnings results before the U.S. stock market opens on Tuesday, May 21, 2024. The Company will conduct a conference call to discuss its earnings results on the same day at 8:30am ET.

NEW YORK, May 01, 2024 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ: WALD) (“Waldencast” or “the Company”), a global multi-brand beauty and wellness platform, today announced its participation in the CreatorIQ Connect Europe conference, which will be held in London on Thursday, May 2, 2024.

2023 Net Revenue of $218.1 millionGroup Combined Comparable Revenue of $212.5 million, a 15.3% increase vs 2022Group Combined Adjusted EBITDA of $24.4 million, up from ($8.8) million in 2022

NEW YORK, April 22, 2024 (GLOBE NEWSWIRE) --

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

WHY: NEW YORK, NY - (NewMediaWire) - April 20, 2024 - Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Waldencast plc (NASDAQ: WALD, WALDW) resulting from allegations that Waldencast may have issued materially misleading business information to the investing public.

NEW YORK, April 18, 2024 (GLOBE NEWSWIRE) --

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

WHY: NEW YORK, NY - (NewMediaWire) - April 17, 2024 - Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Waldencast plc (NASDAQ: WALD, WALDW) resulting from allegations that Waldencast may have issued materially misleading business information to the investing public.

NEW YORK, April 15, 2024 (GLOBE NEWSWIRE) --

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

WHY: NEW YORK, NY - (NewMediaWire) - April 13, 2024 - Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Waldencast plc (NASDAQ: WALD, WALDW) resulting from allegations that Waldencast may have issued materially misleading business information to the investing public.

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

WHY: NEW YORK, NY - (NewMediaWire) - April 11, 2024 - Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Waldencast plc (NASDAQ: WALD, WALDW) resulting from allegations that Waldencast may have issued materially misleading business information to the investing public.

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.